Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Find out which cash back cards offer the best options for 2023. Stay updated with the latest offerings to maximize your rewards.
26,992 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Jim Cramer warned that semiconductor stocks could slide as margin selling weighs on the sector, pointing investors to...
As retail faces slower discretionary spend, Walmart doubles down on automation, ads, and marketplace scale, while Cos...
Intuitive Surgical dominates robotic-assisted surgery, and its moat is getting stronger. This piece breaks down why t...
Teradyne spiked after Micron's strong results suggested AI-driven demand for memory and processing chips remains inta...
A sudden, sizable stake in Resideo Technologies has sent its stock climbing 66%. Alta Fox Capital Management disclose...
As the S&P 500 pushes higher, questions swirl about whether does michael burry know something the market isn’t pricin...
A public misstep can hijack more than your moment in the spotlight. This article uses love island usa’s vasana as a c...
Reddit stock has faced a sharp pullback, but the business fundamentals could be turning a corner. This guide explains...
A CEO’s share sale at Mineralys shines a light on insider moves ahead of a key FDA event. This guide breaks down what...
ATRenew (RERE) 2026 earnings in Q1 offer a clearer view of the company’s path forward. This guide breaks down what to...
Is Rivian a millionaire-maker stock or a high-risk punt? This guide dives into the catalysts, margins, and scenarios ...